Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...